Retention in HIV care has declined since 'Treat All' guidelines introduced

Introduction of guidelines did not result in any improvement in annual viral load monitoring and suppression among people retained in care


[podcast] AIDS responses must be grounded in human rights


This podcast features Dr Ishwar Gilada who had established India's first AIDS clinic in 1986 when first HIV case had got diagnosed in the country. 

Dr Gilada is the longest serving HIV medical expert in India, President-Emeritus of AIDS Society of India, part of Governing Council of IAS (International AIDS Society) and 25th International AIDS Conference organising committee. He is in conversation with CNS Founder and Managing Editor Shobha Shukla.

[podcast] Perspectives of people living with HIV must be central to AIDS response

 
This podcast features UNAIDS India Country Director David Bridger who shares what #PutPeopleFirst means to him in lead up to 25th International AIDS Conference (AIDS 2024) to be held in Munich, Germany. He is in conversation with Shobha Shukla, CNS founder Managing Editor and Executive Director and Chairperson of Global AMR Media Alliance (GAMA).

Timely and accurate diagnosis is the bedrock to stop misuse and overuse of medicines

Drug-resistant disease-causing microbes can infect any one of us. Bhakti Chavan, a promising biotechnologist, who never had TB before, got infected with extensively drug-resistant TB (XDR-TB) bacteria. XDR-TB is one of the most serious forms of TB. After some delay, an accurate XDR-TB diagnosis helped her access the right treatment, thanks to an MSF clinic. With steely resolve and grit, she went through the difficult treatment of XDR-TB and got cured. Not only has she defeated XDR-TB, but she also champions the cause of helping those who are fighting TB as well as drug resistance or antimicrobial resistance worldwide.

AIDS 2024 Affiliated Independent Event (4th July): Find all people with TB & HIV, treat all of them, save lives & stop the spread of both

Watch part-1, part-2

On 4th July, this AIDS 2024 Affiliated Independent Event is on the theme: "Find all people with TB and HIV, treat all of them and prevent any further transmission of both in people-centred ways."

Another feather in the cap of treatment as HIV prevention

- A Groundbreaking HIV Prevention Option -
Results of a phase 3 PURPOSE 1 HIV prevention study done among adolescent girls and young women in South Africa and Uganda show that there were no HIV infections in HIV-negative women who received 6 monthly (twice yearly) injectable investigational drug Lenacapavir - an injectable form of PrEP (pre-exposure prophylaxis) drug developed by Gilead Sciences. In other words, an HIV negative woman will need just two injections a year of this long acting drug to remain safe from acquiring HIV through the sexual route.

[podcast] AMR Dialogues | Dr Sangeeta Sharma speaks on diagnostic stewardship and Antimicrobial Resistance


This podcast features Dr Sangeeta Sharma, Professor and Head, Department of Neuropsychopharmacology, Institute of Human Behaviour and Allied Sciences, Delhi, India. She is also the President of Delhi Society for Promotion of Rational Use of Drugs. Dr Sangeeta Sharma is in conversation with CNS founder and Managing Editor Shobha Shukla (who Chairs Global AMR Media Alliance - GAMA).

Listen to this podcast on Apple Podcasts, Amazon Music, YouTube PodcastsSpotify, TuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, iVoox, and other podcast streaming platforms.

[podcast] AMR Dialogues | Bhakti Chavan, a member of WHO Task Force of AMR Survivors


This podcast features Bhakti Chavan who is a part of World Health Organization (WHO) Task Force of Antimicrobial Resistance (AMR) Survivors. She is in conversation with CNS founder and Managing Editor Shobha Shukla. Shobha is the Chairperson of Global AMR Media Alliance (GAMA).

Listen to this podcast on Apple Podcasts, Amazon Music, Spotify, YouTube PodcastsTuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, iVoox, and other podcast streaming platforms.

[podcast] Decentralise people-centred services to find all, treat all and prevent all TB among people living with HIV


This podcast features Dr Rajesh Kumar Sood, District Programme Officer, National Health Mission, Kangra, Himachal Pradesh, India. He shares what #PutPeopleFirst means to him in the lead up to the 25th International AIDS Conference (AIDS 2024).

Are we on track to end AIDS, end viral hepatitis and end STIs by 2030?

[watch the video or listen to podcast] Well, it seems to be a mixed bag of gains and losses. While there are reasons to celebrate, significant gaps remain to be plugged. The latest Global Health Sector Strategies Report of the World Health Organization (WHO) shows that while there has been a substantial increase in expanding service access for HIV, viral hepatitis and sexually transmitted infections (STIs), 2.5 million people are still dying every year due to these three infections. Thus, these illnesses continue to pose a major global health challenge.

From the frontlines: Homeless person won over alcoholism, survived floods and defeated TB

After suffering debilitating TB symptoms for over a year, a homeless person got lifesaving help from a community health worker. Thanks to her, he was eventually diagnosed with TB of the lungs and put on treatment, quit alcohol, and survived one of the worst Delhi floods during his treatment, and got cured.

Right diagnostic test and right treatment at the right time can prevent antimicrobial resistance

New guidelines were launched in India's capital Delhi to help healthcare personnel rightly diagnose and treat people in a timely manner. Failure to do so is fuelling antimicrobial resistance (AMR). Early and accurate diagnosis and treatment (without any delay), with medicines that work on a person, along with standard infection control and disease prevention efforts, remain a cornerstone for public health. And yet this is a distant dream for many in need.

[podcast] Are we on track to end malaria by 2030?

This podcast features insights from a range of experts who spoke in End Malaria Dialogues held around the 77th World Health Assembly of World Health Organization (WHO). Experts include: Dr Michael Adekunle Charles, CEO RBM Partnership to End Malaria; Dr Marijke Wijnroks, Head of Strategic Investment and Impact Division, The Global Fund; Sriram Natarajan, co-founder and CEO Molbio Diagnostics; Prof Maxine Whittaker, Community Representative at the Global Fund Regional Artemisinin Resistance Initiative; and CSO Platform advisor; Aloyce Urassa, Chairperson African Leaders Malaria Alliance (ALMA) Youth Advisory Council; Louis Da Gama, board member, Communities Delegation Unitaid and CSO Platform advisor; and Shobha Shukla, founder Managing Editor and Executive Director, CNS (moderator).

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, TuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, iVoox, and other podcast streaming platforms.

Protect the medicines that protect us

Protect the medicines that protect us and ensure that all those who need them can access them... So said Dr Tedros Adhanom Ghebreyesus, the Director General of The World Health Organization (WHO), at the Strategic Roundtable on "Charting a new path forward for global action against antimicrobial resistance (AMR)" held recently during the 77th World Health Assembly (decision-making body of the WHO which is attended by all countries part of the UN health agency WHO).

Indonesia is enforcing stronger anti-tobacco measures despite industry interference

There is plenty of scientific evidence to show that tobacco kills one out of every two of its users (as per the WHO). Tobacco use devastates lives and fractures families killing over 8 million people every year – year after year. While governments are enforcing stronger evidence-based tobacco control measures, the tobacco industry is conniving to lure children and young people into addiction traps and reap bigger profits by selling its deadly products.